Andreas Halvorsen (Viking Global) trim BioMarin Pharmaceutical Inc.
Andreas Halvorsen (Viking Global) trim $675.5M of disclosed value in BioMarin Pharmaceutical Inc..
Signal
Investor Move
Action
Trim
Capital
$675.5M disclosed value
Why it matters
This action comes from parsed SEC 13F holdings and highlights where tracked institutional capital changed materially versus the previous comparable filing period.